Philip Morris
Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
Fields
- Author
- Huber, G.L.
- Pandina, R.J.
- Type
- PUBL, PUBLICATION, OTHER
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Natl Inst on Drug Abuse
- Seminars in Respiratory Medicine
- Who, World Health Org
- American Psychiatric Assn
- Anatomy of Melancholy
- Legends of Good Women
- Natl Inst on Alcohol Abuse + Alcoholism
- Named Person
- Burton, R.
- Chaucer, G.
- Freud, S.
- Hart, J.P.
- Huber, G.L.
- Surgeon General
- Wyclif, J.
- Xxadam
- Xxeve
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Rutgers Univ
- Seminars in Respiratory Medicine
- Thieme Medical Publishers
- Univ of Tx
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
1
~ Seminars in
i Respiratory Medicine
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
January 1990
Volume 11 Number 1
Appetitive Functions and Dysfunctions: Tobacco
Gry L. Huber, M.D.,* and Robert J. Pandina, Ph.D.t
The past three decades of interest in tobacco
and health have been noteworthy. Nearly a hun-
dred thousand publications now directly or indi-
rectly have addressed most of the more important
relevant issues; many, but not all, of these have
been summarized extensively in 20 reports from
the Surgeon General's office on the health conse-
quences of tobacco use, the last of which empha-
sized 25 years of accomplishments in reducing the
use of tobacco products-since the initial such report
in early 1964. The last issue of Seminars, in 1989,
was devoted to an overview of the more classic con-
siderations of smoking and health topics-the his-
tory, economics, and political influence of tobacco,
the chemical and biologic properties of cigarette
smoke and various other tobacco products, and
highly focused reviews of those pulmonary diseases
that are most frequently associated with tobacco
use and abuse.
It would be difficult to imagine that there are
significant numbers of people in the developed
world who have not heard or been warned about
the potential health effects of cigarette use. As a
result of a variety of factors, per capita tobacco
consumption has continued to decline, there are
significantly fewer smokers in this country today
than there were 25 years ago, and`smoking cessa-
tion efforts and antismoking endeavors on all
fronts are now at an all-time high. Nevertheless, 50
million or more Americans continue to smoke, to-
tal domestic cigarette production remains at an
annual level well above that at the time of the Sur-
geon General's first report 25 years ago, the export
of cigarettes manufactured in the United States to
foreign countries has continued to increase each
year by leaps and bounds, worldwide tobacco pro-
duction reached 6.5 million metric tons last year,
and the tobacco industry is as robust and healthy as
ever. Clearly, tobacco remains overall in great de-
mand. Large numbers of people continue to smoke
very large numbers of tobacco cigarettes.
The objective of this issue of Seminars is "to
look forward." Some of the less frequently consid-
ered, but in many ways more important, issues
concerning tobacco and health will be addressed
critically. Foremost among these is the question of
nicotine dependency or addiction and the role of
tobacco use in associated human behavior. This is a
most difficult task, for so much of what we think we
know is, in fact, still conjectural and the data quite
soft. Indeed, even the definitions of words are de-
bated. In this context, tobacco cigarette smoking
can be considered in the general framework of ap-
petitive functions.
The word "appetite" probably was introduced
into the English language late in the 14th century
by John Wyclif (c 1330-1384), then of Oxford, in
the philosophical Biblical translations he instigated
as an extreme opponent of realism and the abuses
of the Church. The English version was derived
fi;om the French apetit, which in turn surely came
from the Latin appetitus, meaning a "desire to-
O
~
* Univeniry of Texas Health Center, Tyler, Texas,
t Center of Alcohol Studies. Rutgers University, Piscataway, New Jersey
Reprint requests: Dr. Huber, Department of Medicine, Box 2203, Tyler, TX 75710
Copyright C 1990 by Thieme Medical Publishers. Inc., 381 Park Avenue South, New York. NY 10016.
All rights reserved.
1
CD
C,C
Oo
w
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
SE:rIINARS IN RESPIRATORY MEDICINE-VOLUME 1 t, NUMBER 1. f.-LVC'.ARY 1990
ward." Wvciif asked, in Ezekiel XXI, "Whidir eu-
ere is the appetit. or desier, of thi facer" Wyclif was
condemned and banished. Geoffrey Chaucer (c
1343-1400) was much influenced by Wyclif and in
many ways knew a lot more about appetites and
other manifestations of human behavior: he used
the word first in his Legends of Good Women in 1385.
Nearly two centuries later, Robert Burton (1577-
1640), another Oxfordian, referred to "concupis-
cible and irascible appetites ... twining about the
heart" in his The Anatomy of NfelancholY.
Today, the use of this word has evolved to
most commonly associate "appetites" with eating,
hunger, or a craving for food. Its prime meaning,
however, has a broader context, particularly in
the behavioral sciences. In a more literal sense,
appetite means a "bent of the mind toward the
attainment of an object or purpose," or a desire,
inclination, fancy, or disposition of human behav-
ior. Appetitive behavior may be conscious or un-
conscious, or both. Despite the now voluminous
publications, we today really know very little about
appetitive function, either at the molecular level,
where controlling mechanisms have been postu-
lated for the central nervous system, or at the be-
havioral level, where modification is difficult. It is
becoming ever more clear that the ultimate acts of
behavior are a final product of genetic coding, im-
printing, and programming during early life, and
modulation by conscious and unconscious influ-
ences throughout one's entire existence. Generally,
however, moderate appetitions are healthy, fulfill-
ing the natural necessities and functions of life that
preserve the body. Appetidve dysfunctions occur
when moderation is lost and these drives become
excessive, absent, or dysregulated. Appetidve dys-
functions can become extremely unhealthy, in-
deed, life threatening.
Americans have enormous, at times almost un-
fathomable appetites, as do many others in most
Western modernized countries. This is also true
now with increasing intensity in the Orient, espe-
cially in Japan and China. Perhaps a tendency to
appetency has been inherent to human nature
since the beginning of our existence, whenever and
wherever it could be afforded. There has always
been a price to pay for excessive appetitions, as
noted throughout all recorded history, in religion,
and in mythology--just ask Adam and Eve! Af-
fordability is key, for many appetites, especially in
the United States, are quite costly; appetent dys-
function is extremely even more expensive, both
for the individual and progressively ever more so
for the society in which that individual resides.
What are America's appetites and appetitive
dysfunctions? They are quite numerous and only a
2 few will be mentioned in limited detail here in or-
der to place the use of tobacco in some relative
perspective. First and perhaps by far foremost.
both in terms of prevalence and in terms of cost,
Americans eat too much. Some recent polls indi-
c3te that at any one time as many as one third of all
Americans are dieting to lose weight, and another
one third are thinking about starting a diet or have
just finished one. Even with pockets of nutritional
deprivation, we are a nation of excessive abun-
dance in food products, and overall a nation of
excessive food consumption. Eating what are
thought to be the "wrong" foods is projected as a
health hazard, to the point of oversaturation, in
the daily lives of all consumers. Someone in Amer-
ica dies about every 30 seconds from cardiovascu-
lar disease due to an "excess" in risk factors.
Appetitiveiy, there are more than 113 million
Americans who have consumed ethanol in the past
month, at least 10 or 12 million or more of them
with a significant dependency and "a drinking
problem." The use of alcohol dates back to prehis-
toric times. It was regulated in use by the Code of
Hammurabi in 1700 BC, and well before that in
other cultures. The rate of alcohol use, and abuse,
as an appetitive dysfunction has been increasing in
females. The National Institute on Alcohol Abuse
and Alcoholism has budgeted $110 million this
coming year for research on this appetitive disor-
der, up from about $81 million last year. Excessive
use of alcohol by Americans is believed to contrib-
ute about 130,000 or so excess deaths each year
to the nation's overall mortality, but the actual
number may be much higher. Alcohol-related dys-
functions cost the United States an estimated $31
billion or so annually in lost work and lost produc-
tivity, about $15 billion in health care, and a pro-
jected $70 billion or more in other areas.
A heroic endeavor was made in the SurgFon
General's report in 1988 to link tobacco use to al-
cohol abuse and, by "a case of guilt by association,"
to those illicit drugs generally associated with de-
pendency. As an appetitive dysfunction, giving
pleasure "beyond the range of normal experience,"
an estimated 30 million Americans have tried co-
caine on one or more occasions, 12 million have
used cocaine within the past year, 6 million use it
regularly for "recreational pleasures," and an ad-
ditional 3 million are allegedly "addicted." Derived
from cocoa leaves first in Peru now nearly 2 mil-
lennia ago, cocaine extraction for medicinal pur-
poses was widely used by the mid-19th century.
Although generally not considered a "narcotic," co-
caine fell under regulation by the Harrison Nar-
cotic Act in 1914. Sigmund Freud was able to end
his "addiction" to cocaine, but not his use of to-
bacco, succumbing in his 83rd year to the compli-
cations of throat cancer.
i

I
I
I
I
I
I
I
I
I
I
I
I
I
a
I
I
I
.aPPETITIVE FI,'NCTIONS .4ND DYSFL'NCTIO[vS OF TOBACCO-Hc,'BER. PAND[NA
Opium was used at least by 4000 BC, and its
effects were extensivelv described in 300 BC. Mor-
phine was extracted from opium in 1805, and her-
oin in 1875. The Surgeon General estimates that
there are at least 4000 excess deaths each vear from
opiates, but other projections vary widelv. Regard-
less, to meet their particular appetitive needs,
about 1.5 million Americans appear to be "lifetime"
users of opiates. Illicit drug appetitive dysfunctions
are estimated to cost the nation $24 billion annu-
ally in lost time and productivity, $2 billion or more
in excessive health costs, and more than $33 billion
in other ways, but any such projections are highly
conjectural. The National Institute on Drug Abuse
has budgeted $173 million for research this year,
up from $132 million last year. Included in this
budget is $25 million earmarked for the develop-
ment of therapeutic drugs, which are to be used in
the control of excessive drug use. The President
has launched a $6 billion "drug war," which can be
considered at best only a beginning for a problem
of increasing enormity.
Marihuana, once tried by as many as 80% of
our nation's students, has now become almost the
"forgotten drug" in American culture. Neverthe-
less, 60 to 70 million people in this country have
used marihuana once or more in their lifetime, 30
million or so within the past year, and probably 20
million or more on a fairly regular but, generally,
intermittent basis. The adverse health effects, costs
from loss of activity and productivity, and the like,
all remain obscure.
Appetitive functions and dysfunctions do not
end with considerations of tobacco, alcohol, or il-
licit drugs. About 18 million Americans have used
prescribed or licit stimulants, 7 million of them in
the past year, and more than 2 million on at least a
monthly or more regular basis. About 15 million
Americans have used tranquilizers and nearly 12
million have used sedatives. Clearly, the lifestyle in
this country, as well as in many other nations,
incorporates--indeed, even depends on-an enor-
mous need to fill our•aggregate appeticive func-
tion. New generations of substances, such as crank,
croak, P-funk, bosco, ice, and moon rock-are ap-
pearing with ever increasing frequencies as "new
models" of illicit substances, as the search contin-
ues to experience euphoria, or to stave off depres-
sion, or just to cope.
Addiction is a concept that is difficult to de-
fine. The World Health Organization prefers the
nomenclature of "drug dependence," whereas the
American Psychiatric Association uses the terms
"substance abuse" and "substance dependence."
Perhaps the best understanding is achieved when
these behaviors are viewed as compulsions. Com-
pulsions are not limited to substances, however,
and in the broad concept of appetitive functions
would include gambling, watching television, exer-
cising, and working. The key questions might be:
"Is the behavior rewarding%" or "Is the substance
rewarding%" Rewarding experiences promote de-
sire for repetition. If ultimately rewarding, the per-
son using the substance will "give" himself or
herself the agent repeatedly. Rewarding sub-
stances, like rewarding behaviors, usually result in
a change in mood or in brain function, and this
effect usually increases with increasing "doses" of
the pharmacologic substance or behavior. Demon-
strable changes in central nervous system pathways
or mediators are not necessarily essential, however,
in all instances. For example, some people behave
as if they were addicted to chocolate ice cream, or
to exercise, or to other behaviors.
Etiologic mechanisms at play in the develop-
ment of appeticive disorders are far from under-
stood. A broad range of factors from biologic,
psychologic, and sociologic domains have been
cited as "critical." To date, the search for specific
(or for that matter, global) markers for and mech-
anisms of vulnerability or "addiction proneness"
have not met with much success when the bench-
mark of success is explanatory power. This obser-
vation appears valid irrespective of analysis level
(biologic, psychologic, or sociologic) or substance
type (such as tobacco, alcohol, heroin) or behavior
of interest (such as drug use, food intake, garn-
bling, exercise). For example, it appears that any
living creature, human or animal, has the biologic
potential for repetitive compulsive behavior or
what may be loosely termed "addiction." The de-
velopment of this behavior does not require an
absolute genetic predeterminance even though a
predisposing biologic substratum would seem to be
an appealing mechanism in a number of appecidve
disorders. In a similar vein, no specific addictive or
dependent personality trait has been identified
even though difficulty in emotional regulation (es-
pecially, in coping with negative affectivity) appears
to characterize those at high risk for appecitive dys-
functions. Furthermore, no single set of environ-
mental conditions can be said to elicit "addiction,"
although high stress-high demand scenarios
(whether they be those created in the opportunity
rich corporate board rooms or the impoverished
environment of the inner city ghetto) seem to be
likely fostering media. Perhaps it is the lack of an
overwhelming etiologic factor that has led to spec-
ulation that, at least for drug dependence, or, at
least for some drugs (such as, n,cotine), the "an-
swer" lies in the pharmacologic properties of the
drug rather than in the characteristics of the host
or the environment. It 'seems, of course, more
likely that factors from each realm of analysis will
3

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
4
I
SEMINARS IN RESPIRaTORY MEDICINE-VOLUME 11, NUMBER 1. J,i.VC"ARF 1990
be found ultimatelv to make sizeable contributions
to the final equation that links the causes and con-
sequences of and, possibly, commonalities among
appetitive dysfunctions.
Finally, we would ask you to keep in mind the
implications of this collection of articles in future
attempts at the design of interventions aimed at
blocking initiation or interrupting on-going use.
No matter which level of analysis is considered,
conclusions are similar and disturbing in large
measure. Significant numbers of persons drawn
from all walks of life continue to initiate and main-
tain use despite unprecedented efforts to influence
their decisions either through educational efforts
(such as school-based educational programs, media
campaigns) or more direct social or legislative ac-
tions (such as restrictions in product availability
or use opportunity). Furthermore, treatment
interventions whether pharmacologic (such as am-
ethvstetic agents), behavioral, medical, or multi-
component in nature yield relatively modest initial
cessation rates and even less impressive longer
term success rates. In these regards, control of to-
bacco use shares common ground with control of
other appetitive dysfunctions and, perhaps, it may
be we can learn and extrapolate from our tobacco
lesson. Considering the potentially damaging con-
sequences of appetitive dysregulation, it seems im-
perative that any progress we have made during
the past 25 years be scrutinized carefully for clues
that can serve as our guide for the 21st century.
We gratefully acknowledge the editorial assistance
and other help provided by Professor J. Paxton Hart in
the preparation and review of all of the articles in this
issue of Seminars.
